Loading...
Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare haematological malignancy defined by concurrent expression of CD4, CD56, BCL-2 and CD123. The disease has a very poor prognosis and there are no well-established treatment guidelines. We describe a case of BPDCN in a 65-year-o...
Saved in:
| Published in: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6663200/ https://ncbi.nlm.nih.gov/pubmed/31308179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230332 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|